Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sergei V. Sharabrin"'
Autor:
Ekaterina V. Starostina, Sergei V. Sharabrin, Denis N. Antropov, Grigory A. Stepanov, Georgiy Yu. Shevelev, Anna E. Lemza, Andrey P. Rudometov, Mariya B. Borgoyakova, Nadezhda B. Rudometova, Vasiliy Yu. Marchenko, Natalia V. Danilchenko, Anton N. Chikaev, Sergei I. Bazhan, Alexander A. Ilyichev, Larisa I. Karpenko
Publikováno v:
Vaccines, Vol 9, Iss 5, p 452 (2021)
Nucleic acid-based influenza vaccines are a promising platform that have recently and rapidly developed. We previously demonstrated the immunogenicity of DNA vaccines encoding artificial immunogens AgH1, AgH3, and AgM2, which contained conserved frag
Externí odkaz:
https://doaj.org/article/80426bd3388541168ee3c8be27c98539
Autor:
Larisa I. Karpenko, Andrey P. Rudometov, Sergei V. Sharabrin, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Sergei I. Bazhan, Ekaterina A. Volosnikova, Nadezhda B. Rudometova, Lyubov A. Orlova, Inna A. Pyshnaya, Boris N. Zaitsev, Natalya V. Volkova, Mamedyar Sh. Azaev, Anna V. Zaykovskaya, Oleg V. Pyankov, Alexander A. Ilyichev
Publikováno v:
Vaccines, Vol 9, Iss 2, p 76 (2021)
One of the key stages in the development of mRNA vaccines is their delivery. Along with liposome, other materials are being developed for mRNA delivery that can ensure both the safety and effectiveness of the vaccine, and also facilitate its storage
Externí odkaz:
https://doaj.org/article/96c4c28d3711457dacda9271f9dcb895
Publikováno v:
Vavilovskij Žurnal Genetiki i Selekcii, Vol 24, Iss 7, Pp 802-807 (2020)
Vavilov Journal of Genetics and Breeding
Vavilov Journal of Genetics and Breeding
After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd71aa971a4fedb7df2f2f8255e60ea0
https://vavilov.elpub.ru/jour/article/view/2824
https://vavilov.elpub.ru/jour/article/view/2824
Autor:
Alexander A. Ilyichev, Larisa I. Karpenko, Sergei V Sharabrin, Georgiy Yu. Shevelev, Ekaterina V Starostina, Anton N. Chikaev, Bazhan Si, Vasiliy Y. Marchenko, A. P. Rudometov, Mariya B Borgoyakova, Denis N Antropov, Nadezhda B. Rudometova, Natalia V. Danilchenko, G. A. Stepanov, Anna E Lemza
Publikováno v:
Vaccines, Vol 9, Iss 452, p 452 (2021)
Vaccines
Volume 9
Issue 5
Vaccines
Volume 9
Issue 5
Nucleic acid-based influenza vaccines are a promising platform that have recently and rapidly developed. We previously demonstrated the immunogenicity of DNA vaccines encoding artificial immunogens AgH1, AgH3, and AgM2, which contained conserved frag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca5fefdb587185cab4edd54401a2bd2
https://www.mdpi.com/2076-393X/9/5/452
https://www.mdpi.com/2076-393X/9/5/452
Autor:
Mamedyar Sh Azaev, Anna V. Zaykovskaya, Natalya V Volkova, Ekaterina A Volosnikova, Oleg V. Pyankov, Inna A. Pyshnaya, Larisa I. Karpenko, A. P. Rudometov, B. N. Zaitsev, Bazhan Si, Alexander A. Ilyichev, Lyubov A Orlova, Mariya B Borgoyakova, Sergei V Sharabrin, Dmitry N. Shcherbakov, Nadezhda B. Rudometova
Publikováno v:
Vaccines, Vol 9, Iss 76, p 76 (2021)
Vaccines
Volume 9
Issue 2
Vaccines
Volume 9
Issue 2
One of the key stages in the development of mRNA vaccines is their delivery. Along with liposome, other materials are being developed for mRNA delivery that can ensure both the safety and effectiveness of the vaccine, and also facilitate its storage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4da608e2fcf2dc7ae5e5ac50e5b27b
https://www.mdpi.com/2076-393X/9/2/76
https://www.mdpi.com/2076-393X/9/2/76